earnings
confidence high
sentiment positive
materiality 0.65
Inogen Q3 revenue $92.4M (+4% YoY); adj. EBITDA positive $2.3M; raises FY guidance
Inogen Inc
2025-Q3 EPS reported
-$0.59
revenue$266,947,000
- Revenue $92.4M, up 4% YoY; seventh consecutive quarter of mid-single-digit growth.
- GAAP net loss $5.3M vs $6.0M loss; adjusted net loss $0.5M vs $2.6M loss.
- Adjusted EBITDA $2.3M (third consecutive positive quarter); full-year adj. EBITDA guidance raised to ~$2M.
- Cash $124.5M, no debt; initiated limited U.S. release of Simeox airway clearance device.
- Gross margin 44.7% down from 46.5% due to higher B2B sales mix.